CDKN2A and acute lymphoblastic leukemia: Most investigators have concluded that the deletions were associated with the recurrence of pediatric ALL (7, 9, 10), and some researchers found that the inactivation of CDKN2A/B did not influence the outcome of childhood B-lineage ALL (4, 11).